Marktkapital. 50,62 Mio. USD
Shares Out 51.1M
Cash, cash equivalents and short-term investments totaled $77.8 million as of September 30, 2019, We believe that our existing cash, cash equivalents and short-term investments are sufficient to fund our operations into 2021
7.11.2019 Q3 2019
Proteostasis Therapeutics (NASDAQ:PTI): Q3 GAAP EPS of -$0.25 beats by $0.15.
Da sollte dieses Jahr noch was kommen
Topline data should be available this quarter instead of Q1 2020.
https://seekingalpha.com/news/3515412-proteostasis-14-percen…
Schreiben Sie hier Ihren Beitrag zu
Proteostasis Therapeutics